Skip to main content

Table 2 Participant characteristics

From: Prolonged-release opioid agonist therapy: qualitative study exploring patients’ views of 1-week, 1-month, and 6-month buprenorphine formulations

  Total (n = 36)
Sex
 Male 26 (72%)
 Female 10 (28%)
Age (years)
 Mean (range) 45 (24–63)
Ethnicity
 White/White British 24 (67%)
 Black/Black British 5 (14%)
 Asian/Asian British 1 (3%)
 Mixed or multiple 3 (8%)
 Other 3 (8%)
Current prescribed medication
 Daily oral methadone 12 (33%)
 Daily oral buprenorphine 12 (33%)
 Daily heroin (not in treatment) 12 (33%)
Frequency of medication collection from a pharmacy
 Daily 16 (44%)
 2–3 times a week 5 (14%)
 Weekly 3 (8%)
 Not applicable 12 (33%)
Current heroin use
 Yes 21 (58%)
 No 15 (42%)